SIAM Conference on Optimization (OP26)
Meeting Announcement
At AACR 2026, Insilico will unveil four novel cancer inhibitors discovered via its end-to-end Pharma.AI platform. By harnessing trillions of data points and millions of molecular fragments, the platform integrates generative biology for target discovery with generative chemistry for de novo molecular design, accelerating the path from data to drug candidates.
NCCN brought together more than a thousand oncology professionals at the NCCN 2026 Annual Conference in Orlando, Florida, with hundreds more joining virtually. This year’s event featured educational sessions on the latest breakthroughs in cancer prevention and treatment, clinical guidelines updates, guidance for improving cancer center operations, plus panel discussions on critical issues in care delivery.
More than seventy years after Alan Turing posed the question of whether machines could think, advances in artificial intelligence have shifted the focus from imitation to collaboration. As AI increasingly undertakes complex academic tasks through multi-agent collaboration, a new question emerges: beyond the Turing Test, how should the human role in research be redefined?
After decades of progress, longevity science may be facing a paradox: more knowledge, but limited impact. Some researchers now suggest the field may have failed not because of insufficient data, but because of flawed strategy.
First female Mount Sinai cardiologist to hold this prestigious position